Company Overview of Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies to enhance treatment outcomes. The company’s development portfolio includes ITCA 650, an injection-free GLP-1 therapy for the treatment of Type 2 diabetes; and additional programs for weight regulation to control obesity. Intarcia Therapeutics, Inc. was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. The company was incorporated in 1995 and is headquartered in Hayward, California.
24650 Industrial Boulevard
Hayward, CA 94545
Founded in 1995
Key Executives for Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Beech Tree Labs, Inc.||United States|
|Actavis South Atlantic LLC||United States|
|Naryx Pharma, Inc.||United States|
|Ibis Biosciences, Inc.||United States|
|IMI International Medical Innovations, Inc.||United States|
Recent Private Companies Transactions
November 14, 2012
August 7, 2012
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Seattle, WA | Marina Sirras & AssociatesPosted: Apr 09
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Waltham, MA | Nova BiomedicalPosted: May 16
Sponsored Financial Commentaries
To contact Intarcia Therapeutics, Inc., please visit www.intarcia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.